EndOxy (finished 12/2017)
Chronic airway disease is the third most frequent cause of mortality. However, the therapy of chronic lung disease is limited to a duration of weeks due to insufficient biocompatibility of extracorporeal membrane oxygenation (ECMO) devices. The underlying idea in the research project “EndOxy” is to overcome this limitation by benefitting from the physiological antithrombotic properties of an endothelial lining similar to the native blood vessels. A biohybrid solution with endothelial layer covering the blood contacting surfaces as a biomimicking interface between technical promises an increase of hemocompatibility and, thus, allows prolonged ECMO therapy for patients with chronic lung disease.
HOC Surf (finished 07/2019)
People who live with an implanted ventricular assist device have to fuly rely on this. The fact that todays ventricular assist devices come with a life-threatening risk of thrombosis is even more severe for those being affected. Therefore, CVE and its cooperation partners investigate in the project HOC Surf intensively the applicability of innovative coating processes. It is our goal to enable patients to live their lifes without any risk of thrombosis through a gentle contact between blood and device.
Isolated Heart (finished 06/2016)
The Isolated Heart is a standardized test procedure for percutaneous aortic valve prostheses.
ProtEmbo (finished 10/2018)
The acute aortic valve stenosis is one of the most commonly observed heart valve diseases. Affected patients with a high operation risk are treated with transcatheter aortic valve implantation (TAVI), a minimally invasive procedure. This procedure comes with several risks. The development of a novel embolic protection device, the ProtEmbo device, is expected to minimize neurological complications during TAVI.
ReinHeart (finished 03/2018)
Aim of the project ReinHeart is the development of a fully implantable total artificial heart that functions without any connection through the skin